Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079220270> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2079220270 endingPage "77" @default.
- W2079220270 startingPage "77" @default.
- W2079220270 abstract "Strippoli GF, Craig M, Deeks JJ, et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 2004;329:828. [OpenUrl][1][Abstract/FREE Full Text][2] Q In patients with diabetic nephropathy, what are the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists (AIIRAs)? Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ IM/Ambulatory care ★★★★★☆☆ Internal medicine ★★★★★☆☆ Nephrology ★★★★★☆☆ Endocrine ★★★★★★☆ ### ![Graphic][3]</img>Data sources: Medline (1966 to September 2003), EMBASE/Excerpta Medica (1988 to September 2003), the Cochrane Library, conference proceedings, and contact with experts. ### ![Graphic][4]</img>Study selection and assessment: randomised controlled trials (RCTs) in any language of ⩾6 months’ duration comparing ACE inhibitors or AIIRAs with placebo, no treatment, or each other in patients with any stage of diabetic nephropathy. Studies were assessed for methodological quality. ### ![Graphic][5]</img>Outcomes: all cause mortality … [1]: {openurl}?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.38237.585000.7C%26rft_id%253Dinfo%253Apmid%252F15459003%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/ijlink?linkType=ABST&journalCode=bmj&resid=329/7470/828&atom=%2Febmed%2F10%2F3%2F77.atom [3]: /embed/inline-graphic-1.gif [4]: /embed/inline-graphic-2.gif [5]: /embed/inline-graphic-3.gif" @default.
- W2079220270 created "2016-06-24" @default.
- W2079220270 creator A5001846180 @default.
- W2079220270 date "2005-06-01" @default.
- W2079220270 modified "2023-09-27" @default.
- W2079220270 title "Review: ACE inhibitors, but not angiotensin II receptor antagonists, reduce all cause mortality in diabetic nephropathy" @default.
- W2079220270 cites W1986924251 @default.
- W2079220270 cites W2044773944 @default.
- W2079220270 cites W2056976690 @default.
- W2079220270 cites W2097433411 @default.
- W2079220270 cites W2615684303 @default.
- W2079220270 doi "https://doi.org/10.1136/ebm.10.3.77" @default.
- W2079220270 hasPublicationYear "2005" @default.
- W2079220270 type Work @default.
- W2079220270 sameAs 2079220270 @default.
- W2079220270 citedByCount "0" @default.
- W2079220270 crossrefType "journal-article" @default.
- W2079220270 hasAuthorship W2079220270A5001846180 @default.
- W2079220270 hasBestOaLocation W20792202701 @default.
- W2079220270 hasConcept C104849204 @default.
- W2079220270 hasConcept C126322002 @default.
- W2079220270 hasConcept C134018914 @default.
- W2079220270 hasConcept C142724271 @default.
- W2079220270 hasConcept C170493617 @default.
- W2079220270 hasConcept C204787440 @default.
- W2079220270 hasConcept C27016395 @default.
- W2079220270 hasConcept C27081682 @default.
- W2079220270 hasConcept C2776478404 @default.
- W2079220270 hasConcept C2779922275 @default.
- W2079220270 hasConcept C2780091579 @default.
- W2079220270 hasConcept C2908929049 @default.
- W2079220270 hasConcept C71924100 @default.
- W2079220270 hasConcept C84393581 @default.
- W2079220270 hasConcept C90924648 @default.
- W2079220270 hasConcept C95190672 @default.
- W2079220270 hasConceptScore W2079220270C104849204 @default.
- W2079220270 hasConceptScore W2079220270C126322002 @default.
- W2079220270 hasConceptScore W2079220270C134018914 @default.
- W2079220270 hasConceptScore W2079220270C142724271 @default.
- W2079220270 hasConceptScore W2079220270C170493617 @default.
- W2079220270 hasConceptScore W2079220270C204787440 @default.
- W2079220270 hasConceptScore W2079220270C27016395 @default.
- W2079220270 hasConceptScore W2079220270C27081682 @default.
- W2079220270 hasConceptScore W2079220270C2776478404 @default.
- W2079220270 hasConceptScore W2079220270C2779922275 @default.
- W2079220270 hasConceptScore W2079220270C2780091579 @default.
- W2079220270 hasConceptScore W2079220270C2908929049 @default.
- W2079220270 hasConceptScore W2079220270C71924100 @default.
- W2079220270 hasConceptScore W2079220270C84393581 @default.
- W2079220270 hasConceptScore W2079220270C90924648 @default.
- W2079220270 hasConceptScore W2079220270C95190672 @default.
- W2079220270 hasIssue "3" @default.
- W2079220270 hasLocation W20792202701 @default.
- W2079220270 hasOpenAccess W2079220270 @default.
- W2079220270 hasPrimaryLocation W20792202701 @default.
- W2079220270 hasRelatedWork W1966128948 @default.
- W2079220270 hasRelatedWork W1971613811 @default.
- W2079220270 hasRelatedWork W2038657938 @default.
- W2079220270 hasRelatedWork W2069855804 @default.
- W2079220270 hasRelatedWork W2111190158 @default.
- W2079220270 hasRelatedWork W2116962665 @default.
- W2079220270 hasRelatedWork W2126797993 @default.
- W2079220270 hasRelatedWork W2132612653 @default.
- W2079220270 hasRelatedWork W2172198736 @default.
- W2079220270 hasRelatedWork W1996764561 @default.
- W2079220270 hasVolume "10" @default.
- W2079220270 isParatext "false" @default.
- W2079220270 isRetracted "false" @default.
- W2079220270 magId "2079220270" @default.
- W2079220270 workType "article" @default.
!["Strippoli GF, Craig M, Deeks JJ, et al. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 2004;329:828. [OpenUrl][1][Abstract/FREE Full Text][2] Q In patients with diabetic nephropathy, what are the effects of angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists (AIIRAs)? Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ IM/Ambulatory care ★★★★★☆☆ Internal medicine ★★★★★☆☆ Nephrology ★★★★★☆☆ Endocrine ★★★★★★☆ ### ![Graphic][3]</img>Data sources: Medline (1966 to September 2003), EMBASE/Excerpta Medica (1988 to September 2003), the Cochrane Library, conference proceedings, and contact with experts. ### ![Graphic][4]</img>Study selection and assessment: randomised controlled trials (RCTs) in any language of ⩾6 months’ duration comparing ACE inhibitors or AIIRAs with placebo, no treatment, or each other in patients with any stage of diabetic nephropathy. Studies were assessed for methodological quality. ### ![Graphic][5]</img>Outcomes: all cause mortality … [1]: {openurl}?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj.38237.585000.7C%26rft_id%253Dinfo%253Apmid%252F15459003%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx [2]: /lookup/ijlink?linkType=ABST&journalCode=bmj&resid=329/7470/828&atom=%2Febmed%2F10%2F3%2F77.atom [3]: /embed/inline-graphic-1.gif [4]: /embed/inline-graphic-2.gif [5]: /embed/inline-graphic-3.gif"](?object=%22Strippoli%20GF%2C%20Craig%20M%2C%20Deeks%20JJ%2C%20et%20al.%20Effects%20of%20angiotensin%20converting%20enzyme%20inhibitors%20and%20angiotensin%20II%20receptor%20antagonists%20on%20mortality%20and%20renal%20outcomes%20in%20diabetic%20nephropathy%3A%20systematic%20review.%20BMJ%202004%3B329%3A828.%20%5BOpenUrl%5D%5B1%5D%5BAbstract%2FFREE%20Full%20Text%5D%5B2%5D%20Q%20In%20patients%20with%20diabetic%20nephropathy%2C%20what%20are%20the%20effects%20of%20angiotensin%20converting%20enzyme%20(ACE)%20inhibitors%20and%20angiotensin%20II%20receptor%20antagonists%20(AIIRAs)%3F%20Clinical%20impact%20ratings%20GP%2FFP%2FPrimary%20care%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%E2%98%86%20IM%2FAmbulatory%20care%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%E2%98%86%20Internal%20medicine%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%E2%98%86%20Nephrology%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%E2%98%86%20Endocrine%20%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%85%E2%98%86%20%23%23%23%20!%5BGraphic%5D%5B3%5D%3C%2Fimg%3EData%20sources%3A%20Medline%20(1966%20to%20September%202003)%2C%20EMBASE%2FExcerpta%20Medica%20(1988%20to%20September%202003)%2C%20the%20Cochrane%20Library%2C%20conference%20proceedings%2C%20and%20contact%20with%20experts.%20%23%23%23%20!%5BGraphic%5D%5B4%5D%3C%2Fimg%3EStudy%20selection%20and%20assessment%3A%20randomised%20controlled%20trials%20(RCTs)%20in%20any%20language%20of%20%E2%A9%BE6%20months%E2%80%99%20duration%20comparing%20ACE%20inhibitors%20or%20AIIRAs%20with%20placebo%2C%20no%20treatment%2C%20or%20each%20other%20in%20patients%20with%20any%20stage%20of%20diabetic%20nephropathy.%20Studies%20were%20assessed%20for%20methodological%20quality.%20%23%23%23%20!%5BGraphic%5D%5B5%5D%3C%2Fimg%3EOutcomes%3A%20all%20cause%20mortality%20%E2%80%A6%20%5B1%5D%3A%20%7Bopenurl%7D%3Fquery%3Drft.jtitle%25253DBMJ%2526rft_id%25253Dinfo%25253Adoi%25252F10.1136%25252Fbmj.38237.585000.7C%2526rft_id%25253Dinfo%25253Apmid%25252F15459003%2526rft.genre%25253Darticle%2526rft_val_fmt%25253Dinfo%25253Aofi%25252Ffmt%25253Akev%25253Amtx%25253Ajournal%2526ctx_ver%25253DZ39.88-2004%2526url_ver%25253DZ39.88-2004%2526url_ctx_fmt%25253Dinfo%25253Aofi%25252Ffmt%25253Akev%25253Amtx%25253Actx%20%5B2%5D%3A%20%2Flookup%2Fijlink%3FlinkType%3DABST%26journalCode%3Dbmj%26resid%3D329%2F7470%2F828%26atom%3D%252Febmed%252F10%252F3%252F77.atom%20%5B3%5D%3A%20%2Fembed%2Finline-graphic-1.gif%20%5B4%5D%3A%20%2Fembed%2Finline-graphic-2.gif%20%5B5%5D%3A%20%2Fembed%2Finline-graphic-3.gif%22){kind=link}